DRUG
Bright Minds Biosciences
$71.91
+$0.58 (+0.81%)Jul 27, 2026
Key metrics
The numbers that frame DRUG today
- Market cap
- $705.59M
- P/E (TTM)
- -35.1
- EV / FCF
- -32.8
- ROIC
- 9,887.5%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $31.80
- 52wk High
- $123.75
Growth
Revenue and earnings trend for DRUG
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about DRUG
Is Bright Minds Biosciences a good buy?
Hold. Bright Minds Biosciences has strong momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case. We think Bright Minds Biosciences is selling at a high price.
What is the market capitalization of DRUG?
Bright Minds Biosciences's market capitalization is $705.59M.
What is the P/E ratio for DRUG stock?
Bright Minds Biosciences's current P/E ratio is -35.1.
What is the 52-week high for DRUG stock?
The 52-week high for Bright Minds Biosciences is $123.75. The current close of $71.91 is 41.9% below that high.
What is the 52-week low for DRUG stock?
The 52-week low for Bright Minds Biosciences is $31.80. The current close of $71.91 is 126.1% above that low.
Does DRUG stock pay dividends?
Bright Minds Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for DRUG?
Bright Minds Biosciences's Debt / Equity ratio is 0.